Ubaĭdullaev A M, Sharafutdinova G Kh, Ismailov Sh U
Ter Arkh. 1998;70(12):44-6.
To evaluate the influence of su-jok therapy (one of the methods of alternative medicine) in combination with chemotherapy on the course of bronchial asthma.
68 patients have undergone su-jok therapy in combination with drug treatment in accordance with international asthma consensus. Control group of 44 patients received only chemotherapy. The response was assessed by: quantitative indices of asthma course, FEV1, FEF 25, 75, 50, PEF, demand of beta2-agonists, long-term outcomes.
The efficiency coefficient made up 2.64 in patients versus 1.48 in controls. Demand of beta2-agonists reduced 4 times versus 1.6 times, respectively. The degree of improvement of bronchial permeability at the level of distal bronchus was 2 times higher in the study group. Other functional parameters were not significantly different. The period free of exacerbations with hospital care was 1.7 times longer in patients on su-jok therapy.
The su-jok therapy adjuvant to chemotherapy is highly effective.
评估耳穴疗法（替代医学方法之一）联合化疗对支气管哮喘病程的影响。
68例患者按照国际哮喘共识接受了耳穴疗法联合药物治疗。44例患者的对照组仅接受化疗。通过以下指标评估疗效：哮喘病程的定量指标、第1秒用力呼气容积（FEV1）、用力呼气流量25%与75%、50%时的瞬间流量（FEF 25、75、50）、呼气峰值流量（PEF）、β2受体激动剂的使用需求、长期疗效。
患者组的疗效系数为2.64，而对照组为1.48。β2受体激动剂的使用需求分别降低了4倍和1.6倍。研究组远端支气管水平的支气管通透性改善程度高出2倍。其他功能参数无显著差异。接受耳穴疗法的患者无需住院治疗的无发作期延长了1.7倍。
化疗辅助耳穴疗法非常有效。
